Literature DB >> 8188756

Type-1 insulin-like growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiation.

L S Quinn1, B Steinmetz, A Maas, L Ong, M Kaleko.   

Abstract

Using a retroviral vector, we developed a line of C2 mouse skeletal myoblasts, C2-LISN, which expressed high levels of the human type-1 insulin-like growth factor (IGF) receptor. When switched to low serum medium, C2-LISN myoblasts underwent terminal differentiation extremely rapidly compared to control C2 myoblasts. In high serum conditions which were not permissive for differentiation, C2-LISN myoblasts expressed ten-fold higher levels of the myogenic transcription factor myogenin than did control C2 myoblasts. When cultured in low serum medium with both transforming growth factor-beta (TGF-beta) and high concentrations of IGF-I, C2-LISN myoblasts failed to differentiate and grew to very high saturation densities, forming multilayers. Upon removal of TGF-beta, multilayered C2-LISN myoblasts differentiated within 2 days. These results demonstrate that overexpression of the type-1 IGF receptor can amplify signals which stimulate myogenic differentiation. Overexpressed type-1 IGF receptors can also mediate strong mitogenic signals if differentiation is inhibited by TGF-beta. The C2-LISN myoblast cell line may be a useful model to investigate the intracellular pathways which stimulate myogenic differentiation. Additionally, overexpression of the type-1 IGF receptor could provide a strategy to expand populations of differentiation-competent myoblasts for experimental or clinical applications.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8188756     DOI: 10.1002/jcp.1041590302

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

1.  Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21.

Authors:  M A Lawlor; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle.

Authors:  Ana M Fernández; Joëlle Dupont; Roger P Farrar; Sukho Lee; Bethel Stannard; Derek Le Roith
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

3.  Type-1 insulin-like growth factor receptor reexpression in the malignant phenotype of SV40-T-immortalized human prostate epithelial cells enhances apoptosis.

Authors:  S S Plymate; V L Bae; L Maddison; L S Quinn; J L Ware
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

4.  Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I.

Authors:  A Musarò; N Rosenthal
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

5.  Myostatin stimulates, not inihibits, C2C12 myoblast proliferation.

Authors:  Buel D Rodgers; Benjamin D Wiedeback; Knut E Hoversten; Melissa F Jackson; Ryan G Walker; Thomas B Thompson
Journal:  Endocrinology       Date:  2014-01-01       Impact factor: 4.736

6.  An HMGA2-IGF2BP2 axis regulates myoblast proliferation and myogenesis.

Authors:  Zhizhong Li; Jason A Gilbert; Yunyu Zhang; Minsi Zhang; Qiong Qiu; Krishnan Ramanujan; Tea Shavlakadze; John K Eash; Annarita Scaramozza; Matthew M Goddeeris; David G Kirsch; Kevin P Campbell; Andrew S Brack; David J Glass
Journal:  Dev Cell       Date:  2012-11-21       Impact factor: 12.270

7.  New Modulators for IGF-I Activity within IGF-I Processing Products.

Authors:  Becky K Brisson; Elisabeth R Barton
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-27       Impact factor: 5.555

Review 8.  Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs.

Authors:  Buel D Rodgers; Christopher W Ward
Journal:  Endocr Rev       Date:  2022-03-09       Impact factor: 25.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.